Hikma Pharmaceuticals USA Inc. v. Amarin Pharma, Inc. · ¶25

Our well-established federal pleading standards are not up for debate in this case. In order to proceed to discovery, a plaintiff must “state a claim to relief that is plausible on its face.” Bell Atlantic Corp. v. Twombly, 550 U. S. 544, 570 (2007). That plausibility standard “asks for more than a sheer possibility that a defendant has acted unlawfully.” Ashcroft v. Iqbal, 556 U. S. 662, 678 (2009). If the complaint “pleads facts that are merely consistent with a defendant’s liability, it stops short of the line between possibility and plausibility of entitlement to relief.” Ibid. (internal quotation marks omitted). Instead, to nudge a claim “across the line from conceivable to plausible,” a plaintiff must plead facts that, if true, “allo[w] the court to draw the reasonable inference that the defendant is liable for the misconduct alleged,” id., at 678, 680 (internal quotation marks…

slip opinion
Source edition
Passage preview. Read in context for the complete text, notes and references.